BridgeMD
New treatment option for Heart Failure
Official title Heart Failure Virtual Ward Research Study
ClinicalTrials.gov ID: NCT06620653
What this study is testing
- What it's testing
- The main aim will be to evaluate whether a follow-up with virtual wards reduces HF hospitalisation at three months follow-up. Hospital admission will be defined as any hospital admission, or an emergency room stay of more than 24 h requiring IV diuretics.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adult patients (≥ 18 years) with a recent hospitalisation.
- Known ejection fraction and NYHA Class
- Known or de novo Heart Failure
- Patient or carer able to speak and understand English/Irish
- Willing to participate in the study.
You likely can't join if
- Patients who decline to participate in the study.
- Patient in palliative care or with a life expectancy of less than one year.
- Patients referred to skilled nursing facilities or nursing homes at hospital discharge.
- Patients with planned intervention on the mitral or aortic valve during admission or scheduled early after discharge.
- Planned haemodialysis.
- Patients included in other assigned by chance controlled trials.
See the full eligibility criteria
- Adult patients (≥ 18 years) with a recent hospitalisation.
- Known ejection fraction and NYHA Class
- Known or de novo Heart Failure
- Patient or carer able to speak and understand English/Irish
- Willing to participate in the study.
- Within catchment area of the Saolta group.
- Patients who decline to participate in the study.
- Patient in palliative care or with a life expectancy of less than one year.
- Patients referred to skilled nursing facilities or nursing homes at hospital discharge.
- Patients with planned intervention on the mitral or aortic valve during admission or scheduled early after discharge.
- Planned haemodialysis.
- Patients included in other assigned by chance controlled trials.
- Patients who, at the investigator's discretion, are considered unable to participate in the study, mainly due to a previous history of non- compliance with medication and follow-up appointments, language barrier, or...
- Patients with asymptomatic (NYHA class I) left ventricular dysfunction, usually in the setting of an acute myocardial infarction.
- The lack of information technology (IT) literacy will not be an exclusion criterion.
The study team makes the final eligibility decision.
Where it's taking place
- Ballinasloe, Galway, Ireland
Compensation & support
A stipend or compensation may be offered.
Compensation likely.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ballinasloe, Galway, Ireland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.